Towards meeting the research needs of Australian cancer consumers by Carla Saunders & Sally Crossing
Towards meeting the research needs of
Australian cancer consumers
Saunders and Crossing
Saunders and Crossing BMC Research Notes 2012, 5:667
http://www.biomedcentral.com/1756-0500/5/667
Saunders and Crossing BMC Research Notes 2012, 5:667
http://www.biomedcentral.com/1756-0500/5/667RESEARCH ARTICLE Open AccessTowards meeting the research needs of
Australian cancer consumers
Carla Saunders1 and Sally Crossing2*Abstract
Background: There is a growing amount of literature to support the view that active involvement in research by
consumers, especially informed and networked consumers, benefits the quality and direction of research itself, the
research process and, most importantly, people affected by cancer. Our exploratory project focuses on identifying
their priorities and developing a process to assess the research needs of Australian cancer consumers which may
be useful beyond the cancer scenario.
Methods: This project was consumer initiated, developed and implemented, with the assistance of a leading
Australian cancer consumer advocacy group, Cancer Voices NSW (CVN). Such direct involvement is unusual and
ensures that the priorities identified, and the process itself, are not influenced by other interests, regardless how
well-intentioned they may be. The processes established, and data collection via a workshop, followed by a
questionnaire to confirm and prioritise findings, and comparison with a similar UK exercise, are detailed in this
paper.
Results: Needs across five topic areas reflecting cancer control domains (prevention and risk; screening and
diagnosis; treatment; survivorship; and end of life) were identified. Cancer consumers high priority research needs
were found to be: earlier diagnosis of metastatic cancers; the extent of use of best practice palliative care
guidelines; identifying barriers to cancer risk behaviour change; and environmental, nutrition and lifestyle risk factors
for people with cancer. A process for identifying consumers’ research priorities was developed and applied; this
may be useful for further investigation in this under-studied area.
Conclusion: The findings provide a model for developing a consumer derived research agenda in Australia which
can be used to inform the strategic direction of cancer research. Consumers have been seeking a workable method
to achieve this and have worked in collaboration with a major cancer charity, which funds research, to do so.Background
Research is central to improving health and contributing
to overall national development. Australia has made sub-
stantial investments in building and enhancing its health
research capacity in recent years. Despite these efforts
and some notable examples of success [1,2], the overall
picture of progress is a mixed one. Many investments
have failed to result in a positive impact on health pol-
icies and practices.
No public research funding program can afford to ser-
vice all potential health research questions, each pro-
gram must identify priority areas and questions [3].
Within the limits of available funding, it is mostly up to* Correspondence: sally@crossings.com.au
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distribution, and reproduction in any mediumresearchers and funding bodies to decide what research
to perform within a very broad scope of fundable health
research [4]. Yet as Australians experience ever-increasing
levels of multiple chronic illnesses and a range of new in-
fectious diseases such as the H1N1 virus [5], decisions on
research pursuits require judgments that are more firmly
established on the people’s health needs.
Internationally, there is an increasing call for public in-
volvement in identifying health research priorities in-
cluding distinguishing where and why resources should
be allocated [5]. Greater requirements for need-driven
versus science-driven research substantiate the value of
studies where consumers have helped to identify rele-
vant research questions [6-13] and prioritise topics for
the research agenda [8,10,12,14]. Consumer groups such
as Cancer Voices NSW (CVN), publish their members'ed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Saunders and Crossing BMC Research Notes 2012, 5:667 Page 2 of 8
http://www.biomedcentral.com/1756-0500/5/667interest in involvement in research and research prior-
ities on their websites [15,16]. Research has found that
when potential end recipients assist determinations of
research topics, the research results are more likely to
respond directly to a prevailing problem and to be uti-
lised in the real world [10,17,18].
There is currently a limited understanding of the re-
search needs of people affected by cancer in Australia.
Moreover, published projects that specifically determine
needs and gaps are few [19-21]. There is no consensus
on the best methods of prioritising health research gen-
erally or for cancer research particularly.
A previous UK study [22] found the most highly
ranked priority areas were found to be: the impact can-
cer has on life; how to live with cancer and related sup-
port concerns; risk factors and causes of cancer; and
early detection and prevention. The investigators de-
scribe how the participants believed the emphasis in
cancer research had centred on developing treatments
and the experience of managing the impact of cancer on
individuals was felt to have been relatively neglected.
They found that the participants felt that medical re-
search was too focused on discovering new treatments
for cancer and they felt a balance in research effort was
needed so that the personal consequences of cancer and
its treatment were also addressed.
This project set out to investigate the views of those
affected by cancer in New South Wales, Australia on
what they consider should be the key priorities for future
research in this area. The purpose of the paper is to pro-
vide information on the research needs of NSW cancer
consumers and describe the priority setting process so
that interested parties may duplicate the approaches
used. The findings, key issues and challenges in the iden-
tification and utilisation of consumer research needs are
discussed.
Methodology
This exploratory project adopted a participatory ap-
proach, where project ownership was shared with people
affected by cancer. Cancer Council NSW (CCNSW), a
leading non-government cancer charity and research
funder, partnered with Cancer Voices NSW to design
and implement an approach to capture cancer consu-
mers’ research needs. CVN, as a peak Australian cancer
consumer group with members from all areas of the
state of New South Wales had identified this work as a
pressing need. Ethical approval was received from the
CCNSW Ethics Committee.
Constantly communicating with members is a critical,
ongoing aspect of the work of CVN. The organisation
routinely surveys its members to ensure an up-to-date
understanding of the perceptions and experiences of
cancer consumers and to support decisions that will besthelp people affected by cancer. CVN uses knowledge ac-
quisition to support member empowerment and infor-




Cancer consumers, including those impacted by the dis-
ease directly, or indirectly as friends or family members,
were invited to participate through the following chan-
nels: (1) CCNSW website and constituent mail-outs, (2)
CVN’ s newsletter and networks, (3) cancer support
group contacts and cancer care centres, and (4) via a
range of cancer charities and consumer groups. The op-
portunity was also advertised in the volunteer section of
a large, well known recruitment website.
Data collection
The methods used to capture consumer research needs
were developed after careful deliberation of the support,
funding and timeframe within which we were required
to work. A workshop designed broadly on the ‘Global
Cafe’ approach, which had been recommended by CVN,
was the main data collection method selected in this
part of the project. The Global Café process is a tech-
nique for harnessing group experience and views on a
number of topics, and channelling this output into a us-
able data set [23].
Data collected from CVN’s own bi-annual survey on
cancer research needs was included with an invitation to
all participants. They were also asked to provide written
input from their constituencies which was incorporated
within the pre-workshop data to provide a robust list of
consumer research needs.
Prior to and at the commencement of the workshop,
participants were provided with information to clarify
their general understanding of cancer research across
the cancer control spectrum from cancer prevention to
screening, diagnosis, management, survival and end of
life care. This was designed to focus thinking about can-
cer research and lead to more informed discussions of
what should be researched. Each of these five topic areas
became the individual focus of table discussions in the
workshop. Participants at each table were asked to dis-
cuss the topic as a group, giving their rationale for re-
search interests and then record those research topics
they felt to be important on ‘post-it’ notes.
Ideas and conversations of no more than eight partici-
pants at each table were linked and built upon as people
moved to different tables, cross-pollinating ideas for
each topic area and identifying research needs that mat-
tered to their own lived experiences and/or those col-
lected by their consumer network or group. The living
network of conversations evolved through several
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tion until all participants had the opportunity to input
into each of the five topic areas. A cancer researcher or
CCNSW research program staff member acted as an ad-
visor on each table for participants’ questions, and if par-
ticipants required information on research currently
being undertaken in the area. The advisors brought dis-
cussions back to the issue of research needs if discus-
sions began to go ‘off track’. A pre-selected consumer
table host remained at each table and briefed new table
arrivals on previous discussions to ensure each new
group built on the topic in an iterative exchange process.
The needs identified through the small group process
were then fed back by the consumer host to the whole
group and discussed. This enabled an effective summary
of the discussion and also permitted any additional views
not covered in the small group to be raised.
Questionnaire
To verify the workshop results and achieve higher qual-
ity results CVN canvassed their membership of over 300
consumers who had been affected by cancer or were
interested in cancer control via a general postal ques-
tionnaire. A few had attended the workshop. The ques-
tionnaire, planned and developed by SC and CS, and
tested for readability and ease of understanding by an-
other member of CVN, invited personal reflection on
the research needs of consumers. Included with the
questionnaire was an explanation of the workshop
process and results to ensure an understanding among
members of the context within which the questionnaire
was sent. CVN members were asked whether their
needs reflected some or all of those identified in the
workshop. Members were also asked to rate their
research needs from 1 to 5, with 1 being their highest
research priority. They were asked to identify 5 priorities
in each section.
Members were asked to send their responses back to
CVN in the included stamped, return addressed enve-
lope. Details of the process steps employed in the project
are provided below.
Process steps employed in the project
Steps in the consumer research needs and priorities
identification process
1. The requirement for cancer consumer involvement
in identifying research needs is established by
consumers and acknowledged by professional
partners who commit resources and coordination
support to the process.
2. A project reference group is established to support
the design and implementation of the consumer
research needs identification process.3. Consumer research needs identification approach is
clarified and agreed by all parties.
4. Participant recruitment is planned and carried out.
5. Global Café workshop process is developed in detail
by the project reference group.
6. The information needed for the workshop is
identified and assembled, such as on the cancer
control research domains, to help inform
participants’ discussions during the workshop and
help them build on existing knowledge during their
exchanges.
7. Pre-workshop input from members of each
consumer group represented at the workshop and
the results of previous Cancer Voices NSW survey
results are collected for incorporation with the data
and information obtained in the workshop.
8. Workshop conducted as planned using the Global
Café process.
9. The research needs of cancer consumers are
confirmed at the end of the workshop. Follow-up
via an emailed report of the workshop outcomes is
undertaken to ensure that the final research needs
truly reflect the views and advice expressed during
the workshop.
10. Workshop findings are strengthened via CVN
postal questionnaire to members.
11. The final identified priority issues are compared
with a similar project to support the generalisability
of the results and help ensure that the priorities are
not just intrinsic to this project’s particular process
or participants
12. A final report is disseminated to consumer groups,
research funding and research organisationsData analysis
Workshop
Post-it note entries, which were automatically cate-
gorised within each of the five cancer control research
areas discussed by the workshop table groups, were
examined. Repeating issues were identified and sum-
marised. An independent assessment of all data by
two members of the project team (CS and SC) was
undertaken to ensure consistency in the interpretation
of the data.Questionnaire
Member priorities were analysed using SPSS version 16
for Windows [24] and are presented as frequencies.
Open ended responses were examined to identify which
cancer control research domains they belonged to and
then individual responses were classified according to
existing themes.
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Workshop
Thirty two people with direct experience of cancer
across different cancer types responded to the invitation
to participate in the workshop. This number was
accepted as workable for the purpose and the process.
Participants ranged in age from 18 to 72 years. More
females (n=18) than males (n= 14) attended the work-
shop. Consumers identified needs across the five cancer
control research domains with cancer treatment drawing
the greatest number of identified issues. Needs across
the domains (prevention and risk; screening and diagno-
sis; treatment; survivorship; and end of life) ranged from
a better understanding of unhealthy behaviours such as
smoking and sun exposure, to researching factors related
to differences in cancer outcome due to personal and
geographical inequity, and better understanding the can-
cer control needs of vulnerable groups such as older
people, culturally and linguistically diverse and indigen-
ous people. Improvements in health systems and profes-
sional capacity to better meet the needs of the
population and quality of life issues for cancer patients,
carers and significant others were also deemed to be im-
portant areas for inquiry.
An overview of the identified needs within the cancer
research domains from which they were raised are pro-
vided below.
Cancer consumer research needs across the cancer
control spectrum
Prevention and risk
 How can media improve understanding (and
behaviour change) of cancer risk factors linked to
personal behaviours, with attention to confused use
of relative and absolute risk messages?
 Definitive research into nutrition and other lifestyle
risk factors and cancer development
 What are the barriers to cancer risk behaviour
change and how can positive behaviour change be
encouraged?
 What is the need in Australia for a rare cancer
registry to increase volume of and ease of access to
information about these cancers?
 What are the perceptions of cancer in culturally
and linguistically diverse (CALD)
communities?
 How can barriers to prevention be removed and
cancer awareness raised amongst CALD groups?
 How can young people be better supported to
understand cancer risk?
 Further research into cancer clusters
 Further research into environmental risk factors for
cancer development What are the most effective interventions for
dispelling myths and misconceptions about the
causes of cancer in our community?
 Impact of technology on cancer risk – eg mobile
phones, CT scans, etc.
 Degree of impact of multi risks in causing cancers
 Do prevention messages cause unnecessary feelings
of guilt and self blame?
 What is best use of public health dollars re cancer
prevention?
Screening and diagnosis
 How can behaviour be changed to improve cancer
screening rates?
 What steps are needed to increase skin cancer
screening?
 What are the most effective channels for consumers
to access information about cancer?
 What is the cancer screening benefit for 70+ age
group
 What is the scale of exposure to diethylstilbestrol in
the Australian community
 What are the perceptions and barriers to cancer
screening among different cultural groups?
 What interventions work best to increase cancer
screening in different cultural groups?
 What interventions work best to increase cancer
screening in indigenous groups?
 What are the best approaches to meet the cancer
information needs of different groups?
 Investigate genetic testing services in Australia to
determine and compare service effectiveness across
different population groups and localities
 What is the role and capacity of the general
practitioner in encouraging patients to undertake
cancer screening?
 Is general practitioner training to detect early signs
and symptoms of cancer adequate?
 What constitutes a supportive workplace when
cancer is diagnosed?
 How can metastatic cancers be diagnosed earlier,
preferably before symptomatic?
Treatment
 More investigation into targeted therapies and
personalised medicine for all cancers
 Which cancers will benefit from development of
immunotherapy?
 Identify best practice treatment protocols and
guidelines for all rare cancers
 Overview of research relating to patient treatment
profiling for all cancers
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Australians should be fast tracked?
 Determine which advanced cancers have yet to have
treatment guidelines and address
 Are elderly Australians offered adequate cancer
treatment & management?
 What is the difference in cancer treatment decisions
of those living in rural, regional and remote areas?
 What are the preferred treatment choices of CALD
and Indigenous groups in Australia compared with
best practice management?
 Is access to best practice cancer treatment
determined by cost in Australia? What impact does
this have on health outcomes?
 Investigate the extent and causes for the under
representation of particular groups in cancer clinical
trials i.e. older people, rural, minorities etc.
 What are the levels of access to cancer clinical trials
for residents of rural Australia?
 Is there equity in cancer treatment throughout
Australia?
 How can people living in rural areas be best
supported emotionally and financially to receive best
practice cancer management?
 How can elderly cancer patients be best supported
in self management?
 What are the best approaches that health care
providers can use to prevent or alleviate patient guilt
at cancer diagnosis?
 How can medical care providers be best trained to
deliver a cancer diagnosis that is aligned with the
patient and family’s level of understanding,
emotional and support needs?
 How effective is the communication between
different the medical specialists for those with
cancer and unrelated co-morbid conditions?
 To what extent are general practitioners ‘kept in
multidisciplinary care loop’ of cancer patients?
 What value does multidisciplinary care provide
cancer patients?
 What is the currency of cancer specialist and
General Practitioner evidenced based knowledge?
 What is the current and predicted need for
additional geriatric oncologists in Australia?
 More clinical trials investigating the
effectiveness of complementary therapies in
cancer control
 How can greater awareness of clinical trials in
patients and clinicians be better supported?
 How user friendly and accessible is cancer patient
prescription drug information?
 How can we maximise knowledge transfer among
researchers working on different cancer types and
research disciplines? What are the training needs of personal carers of
cancer patients and the current availability of such
training?
 What are the variations in response to pain
management?
 Identify more effective pain management for cancer
patients
 Identify individualised pain management
interventions
 How can chemotherapy be made less toxic?
 How can the side effects of treatment be better
managed?
 What are the different needs of men caring for
women with cancer; and women caring for men
with cancer?
 What is the extent of carers of cancer patients who
are socially isolated and what are their service and
support needs?
 What is the extent of carers of cancer patients who
are depressed and what are their service and support
needs?
 Survivorship
 How can the long term effects of chemotherapy be
best addressed?
 What are the particular needs and wants of people
living with cancer who do not have adequate social
capital?
 What is the level of fear of cancer recurrence among
survivors?
 How can the normalisation process be supported
(helping those affected by cancer get back to
normal)?
 What are the long term effects of repeat diagnostic
or prognostic scans for cancer survivors?
 More studies on the effects of chemotherapy on
long term cognition
 What is the extent (and intervention availability) of
male and female fertility issues post cancer
treatment?
 What are the best approaches that can be used to
establish and sustain cancer support groups in rural
areas?
 Is cancer survivorship related to a greater chance of
personal relationship breakdown?
 How can children caring for adults with cancer be
best supported?
 What information to survivors need and who should
provide it?
End of life care
 What is the extent of use of best practice palliative
care guidelines – for patients, carers and
family? Gaps?
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dignity and control?
 Is access to good information about end of life issues
(carer, practical, financial, legal, psychosocial),
adequate?
 What are the most effective interventions to ensure
palliative care service availability in rural and remote
areas?
 What is the acceptability and impact of a
professional support person in improving the
experience and outcomes of those with advanced
cancer?
 What extent do different social environments
impact on end of life care?
 What are the long term affects and counselling and
support needs of carers after the death of a loved
one?
 What is it that people value about dying at home?
What is it they fear about dying elsewhere?
 What are the needs and areas of unmet needs for
respite care for patients and families?
 What is the impact of differing views about end of
life, of patient and carer, if any?
Questionnaire
Fifty seven (19%) of CVN members completed and
returned the questionnaires. The majority of respon-
dents were female (56%) aged between 61–70 years
(41%). The large majority of respondents reported that
the research needs identified at the forum reflected ei-
ther all or some of their needs (98%) with almost 60%
stating they reflected all their research needs. One third
of members (33%) identified the research question ‘how
can metastatic cancers be diagnosed earlier before they
are symptomatic?’ as their greatest research need. The
second highest priority research questions (32%) were
found to be ‘what is the extent of use of best practice pal-
liative care guidelines?’ and ‘more research into nutrition
and lifestyle risk factors for people with cancer’ Other
high priority research areas include identifying the bar-
riers to cancer risk behaviour change and research into
environmental risk factors.
The most common research priorities across all
respondents’ first to fifth selections were:
 ‘How can the long term effects of chemotherapy be
best addressed?’ (selected in the top five priorities of
77% of respondents)
 ‘How can behaviour be changed to improve cancer
screening rates?’ (selected in the top 5 priorities of
75% of respondents) and
 ‘How can the normalisation process be supported
(helping those affected get back to normal)?’ (selected
in the top 5 priorities of 68% of respondents).Discussion
This exploratory project facilitated identification of can-
cer consumers' priority research needs over five topic
areas reflecting major cancer control domains. These
were found to be earlier diagnosis of metastatic cancers;
the extent of use of best practice palliative care
guidelines; identifying barriers to cancer risk behaviour
change; and environmental and nutrition and lifestyle
risk factors for people with cancer. A process for identi-
fying consumers’ research priorities was developed and
applied; this may be useful for further investigation in
this under-researched area.
The findings of this project should not be considered
in isolation. Consumer research priorities are neither
better than nor a replacement for priorities identified
by health researchers. They are made available via this
project and a range of other published investigations to
support researchers to both understand prevailing con-
sumer concerns and needs, and to support and inform
decisions on what to research. Ideally consumers and
researchers should always work together to identify and
detail research topics.
The paucity of Australian research in this area necessi-
tated the use of a broad exploratory approach. The main
limitation is the generalisability of findings for a larger
population of cancer consumers. However asking
consumer organisation representatives to collect the
research needs of constituents prior to the workshop is
likely to have reduced this problem, as is the comparison
of findings of this project with those of a much larger
UK study. The similarity between our results and the
UK study results suggests that our results are compar-
able to other populations of cancer patients.
A further limitation is the low response rate (19%) to
the postal questionnaire. However, we believe that this
low number can be explained in part by the belief
among numerous CVN members that they had already
provided input on the topic in previous forums. We
therefore believe that the views of non-responders are
not substantially different from responders.
The findings of this project provide the basis for devel-
oping a consumer derived cancer research agenda in
Australia, and can be used to help inform the strategic
direction of cancer research over the longer term. They
also provide direction for cancer care, education and in-
formation funding. Australia does not have adequate
channels through which community members can ex-
press their research priorities or through which they can
receive information about the broad scope and success
of research being made in the fields with which they are
concerned. Lack of recognised processes and resources
to collect and analyse relevant information from consu-
mers represents an important obstacle to context and
culturally sensitive research needs identification in
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health and medical research are growing.
The study sought to harvest diverse input from cancer
consumers on the issues they need addressed through
research. Identifying research needs can be challenging.
What processes should be used to determine needs?
How can this be done in a systematic, ongoing and effi-
cient manner? What timelines for action should be
assigned? This paper adds to the small range of available
successful approaches that can be used to capture the
research priorities of those directly affected. The Global
Café method is a user-friendly approach for generating
meaningful and cooperative discussion within and be-
tween different groups.
It has been argued that consumers do not have ad-
equate understanding to identify useful research prior-
ities [8]. This may have been based on observations of
unsupported individual community members rather than
networked consumers who are members of advocacy
and/or support organisations such as CVN. CVN has
been developing informed consumer representatives for
over a decade, supported by training in advocacy and re-
search, developed in partnership with CCNSW. The in-
formation produced by this project is robust and is
validated to some degree by comparing the findings with
those of the first UK study to involve cancer patients in
a research priorities identification process. Support
issues, such as helping those affected by cancer get back
to normal, were identified in the UK and current project.
Cancer risk factors and early detection were also identi-
fied as priorities in both investigations, as were cancer
information needs, side effects and cancer recurrence.
Decision makers in publicly funded research systems
are under growing pressure to improve priority setting
processes and to be more accountable for research fund-
ing decisions. There is currently no established structure
or mechanism in Australian public research funding
schemes that allows consumer research needs to be
incorporated. Researchers require training to understand
and appreciate what is happening in health and health
care overall, and with those adversely affected by too few
research answers. Long term partnerships with the end
recipients of research provides experiential and context-
ual learning that are the key to ensuring research is of
benefit to and is valued by society. Liaising with intellec-
tual colleagues and attending scientific seminars and
conferences alone are unlikely to provide insight into
the experiences of those with health problems. Research-
ers need to be inspired by the individuals and families of
those in need of the benefits of focussed research.
Conclusion
Earlier diagnosis of metastatic cancers; an understanding
of the extent of use of best practice palliative careguidelines; identifying barriers to cancer risk behaviour
change; and environmental and nutrition and lifestyle
risk factors for people with cancer, were found to be the
most pressing needs of cancer consumers on the subject
of cancer research. The findings of this study offer a
workable process for identifying the research needs of
health consumers and may be applicable to scenarios
other than cancer.
In an era where research is making important progress
in our understanding of disease causation and avoidance,
and identifying real and potential cures, hopes are
pinned on every piece of research to drive more pro-
gress. Today’s more informed society is eager and able
to encourage a purposeful research culture and direc-
tion. Hence, we see the need to build and maintain a
critical mass of researchers who are competent in part-
nering with consumer groups, which in turn can offer
capable consumer representatives. This partnership will
lead to joint needs identification and priority setting,
and to performing quality research of societal relevance.
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